Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v1-EN
Language English English
Date Updated 2024-03-15 2023-06-09
Drug Identification Number 02416433 02416433
Brand name PMS-CIPROFLOXACIN XL PMS-CIPROFLOXACIN XL
Common or Proper name CIPROFLOXACIN XL CIPROFLOXACIN XL
Company Name PHARMASCIENCE INC PHARMASCIENCE INC
Ingredients CIPROFLOXACIN CIPROFLOXACIN
Strength(s) 500MG 500MG
Dosage form(s) TABLET (IMMEDIATE AND EXTENDED RELEASE) TABLET (EXTENDED-RELEASE) TABLET (IMMEDIATE AND EXTENDED RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code J01MA J01MA
ATC description QUINOLONE ANTIBACTERIALS QUINOLONE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2023-07-17 2023-07-17
Actual start date
Estimated end date 2024-10-19 2023-08-07
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments